Bleeding clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • Obsidio™ Conformable Embolic Registry

    Sorry, in progress, not accepting new patients

    OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects who undergo embolization with Obsidio.

    Los Angeles 5368361, California 5332921 and other locations

Last updated: